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Abstract The range and types of performance metrics has recently proliferated in
academic settings, with bibliometric indicators being particularly visible examples.
One field that has traditionally been hospitable towards such indicators is biome-
dicine. Here the relative merits of bibliometrics are widely discussed, with debates
often portraying them as heroes or villains. Despite a plethora of controversies, one
of the most widely used indicators in this field is said to be the Journal Impact
Factor (JIF). In this article we argue that much of the current debates around
researchers’ uses of the JIF in biomedicine can be classed as ‘folk theories’: ex-
planatory accounts told among a community that seldom (if ever) get systematically
checked. Such accounts rarely disclose how knowledge production itself becomes
more-or-less consolidated around the JIF. Using ethnographic materials from dif-
ferent research sites in Dutch University Medical Centers, this article sheds new
empirical and theoretical light on how performance metrics variously shape bio-
medical research on the ‘shop floor.’ Our detailed analysis underscores a need for
further research into the constitutive effects of evaluative metrics.
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How research evaluation shapes the actual production of knowledge is an under-
explored topic in various literatures addressing academic research (Gla¨ser and
Laudel 2007; Woelert 2015). This is surprising given the wave of performance and
audit measures that has swept across public institutions over the past two decades –
leading commentators to claim that we now inhabit ‘audit’ and ‘evaluation’
societies (Power 1997; Dahler-Larsen 2012). One of the primary institutions subject
to such transformations has been the university (Schimank 2005; Kru¨cken et al.
2013). A feature that is often associated with these developments is the dramatic rise
of quantitative performance indicators (Feller 2009; Keevers et al. 2012; Nedeva
et al. 2012).
Despite an abundance of literature on research evaluation from across several
social science fields, how citation-based measures interact with knowledge
production rarely receives attention (Wouters 2014). Science policy studies often
focus on the efficacy of contemporary research evaluation programs, including
proposals for improving methods and performance indicators (c.f. Cozzens and
Melkers 1997; Luukkonen 2014). Higher education studies often adopt a birds-eye
perspective on formal mechanisms of assessment and national evaluation systems
(Fealing 2011; Reale and Seeber 2013), for instance, conducting systematic
overviews of indicators used in different national funding contexts (Geuna and
Martin 2003). Studies describing the rise of ‘New Public Management’ have
positioned indicators as tools used to steer academic institutions towards becoming
more market-oriented organizations (Parker and Jary 1995; Willmott 2011; Leisyte
and Dee 2012), albeit the overall impact of reforms on different higher education
systems is often contested (Bleiklie and Michelsen 2013). Nevertheless, implica-
tions are that academics have become increasingly disciplined by quantitative, pre-
defined, measurable outcomes that fulfill informational and control requirements
within a neo-liberal higher education system (Sauder and Espeland 2009; Shore
2010; Burrows 2012). Although we are by no means dismissive of these concerns,
they can sometimes cut across the more detailed contingencies surrounding
indicator uses in different research settings. This attention to detail becomes
particularly pertinent if one takes seriously the idea that indicators acquire meaning
through contexts of use (Dahler-Larsen 2013).
We develop this ‘constitutive’ focus on indicators through a case study of
biomedical scientists’ uses of the Journal Impact Factor (JIF) in their everyday
knowledge making activities. The JIF is calculated annually by a commercial
company – Thomson Reuters – based on its Journal Citation Reports. Despite its
presence as a long-standing measure of journals’ citation rates, recently there have
been a number of widespread denunciations of the JIF from various collectives and
individuals, particularly in the biomedical field itself. Notable examples of
outspoken critics include Nobel Prize-winning biologist Randy Schekman (2013)
and the San Francisco Declaration on Research Assessment (DORA 2013). The
arguments deployed against the JIF are quite broad-ranging, but typically include
claims that it is summarily misused by researchers, can be misleading when used in
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a number of evaluative contexts, and that it is subject to gaming among journals.
Rather than add to these critical voices per se, our aim is to retrieve the actual
practices that converge around the JIF in day-to-day biomedical research. The
concept of ‘folk theory’ (Rip 2006) is used here to sensitize analysis more toward
members’ own theorizing and appropriation of the JIF in research contexts. For Rip,
folk theories are generalizations about patterns of action which are made in ongoing
practices and which ‘serves the purposes of the members of the various practices’
themselves (Rip 2006: 349). The folk theory concept thus helps to retrieve practices
surrounding the JIF in knowledge making, rather than diagnosing or classifying
general misuses, or prescribing idealized solutions. An additional sensitizing
concept is to treat the JIF as a ‘judgment device’ (Karpik 2010) in knowledge
making, which helps rate, rank, and order judgments hierarchically (cf. Abbott
2014). Shedding new empirical and theoretical light on how an indicator like the JIF
gets incorporated into knowledge production, we hope to provide a platform for
further research into the under-explored area of performance indicator uses in
academic settings.
The data for this article was collected as part of a larger exploratory ethnographic
study into how indicators and evaluation dynamics link to biomedical knowledge
production in the Netherlands. Historically the considerable scientific and societal
relevance attached to biomedicine, as well as the extensive coverage of biomedical
literature in the Web of Science database has led to a certain receptiveness towards
performance indicators in evaluating research in this field (De Bellis 2009; Van Eck
et al. 2013). Developments in size and structure in biomedicine have also led to
proliferation in quantity of literature, presenting researchers with problems of
quality discrimination and ‘information overload’; factors that provided momentum
to promises for adopting bibliometric solutions (Woelert 2013). Dutch University
Medical Centers (UMCs) account for approximately one third of all journal articles
produced in the whole of the Netherlands, and whilst not hosting the entirety of
biomedical research, they nonetheless cover most of it (NFU 2008). Since the end of
the 1990s, eight UMCs were formed through mergers between the respective
universities’ faculties of medicine and academic medical hospitals. Research is one
core activity of UMCs alongside healthcare, teaching, and valorization activities,
and is appraised yearly via professional bibliometric research assessments used for
external monitoring purposes – an unusual rate compared to other fields. We
therefore expected that indicators would be made visible to us in these settings as
observers, yet we did not know how and in what situations they would figure.
The structure of the paper is as follows: first we describe the rationale behind the
methods and choice of field sites. We will then locate our contribution in respect to
other literatures that have discussed researchers’ uses of indicators in general, and
the JIF in particular. Here, we also discuss how the analytic concepts we deploy are
relevant to these discussions and our own analysis. The findings are presented in two
analytic sections. The first attends to the theme of authorship and collaboration
practices in the different UMC research sites and how the JIF intersected these. This
section displays scientists’ own theories about the JIF across different epistemic and
organizational settings, and at particular moments within their research practices,
making visible the propensity for certain work patterns and relations to harden
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around the JIF. In the second analytic section we report how different research sites
mobilized the JIF as a judgment device in planning to submit work-in-progress
manuscripts. These interactions around manuscripts brought to light scientists’ folk
theories linking the JIF to reputation and targeting of journals. Finally, the
implications of the comparative findings for research in sociological studies of
science and higher education will be considered, which calls for a need to re-think
indicators and research evaluation as actual components of academic knowledge
production.
Methods
The research in this paper draws from a project about the performative effects of
bibliometric indicators on biomedical research in the Netherlands.1 Fieldwork was
carried out at two UMCs and at three research groups within each: a molecular cell
biology laboratory, a surgical oncology laboratory, and medical statistics group.
Here we follow works in sociology of science (Knorr-Cetina 1999; Felt et al. 2009;
Whitley et al. 2010) that posit the diversity of epistemic and organizational work
practices in the sciences. The multi-sited scope allows for greater attention towards
interactions between indicators and knowledge production than would be afforded
by a single-sited study. Conducting fieldwork in two separate UMCs (for purposes
of anonymity, hereon Institution A and B) enables a focus on how the local
organizational context of UMCs shapes the dynamics of evaluation and indicator
usage. In addition, we identified three broad registers of biomedical knowledge
production, following institutionalized distinctions between basic, translational, and
applied research at each UMC. This sampling logic is also based on an assumption
that different sub-fields of biomedicine pursue quite distinct patterns of knowledge
production, for instance, in terms of publication and citation practices (Opthof and
Wilde 2011; Van Eck et al. 2013).
Fieldwork at Institution A took place over an 8-month period from September
2012 until April 2013, and at Institution B between April and August 2014. Our
research consisted of document analysis, interviews and observations. Detailed
fieldnotes were recorded of meetings, laboratory-work, presentations, and of
conversations with our informants. Semi-structured interviews were held with
researchers (PhD-students, post-docs and senior staff), technicians, research
managers, and evaluation officers. Topics included organization of the research
teams and departments, formal evaluation, uses of indicators, scientific careers,
funding, and publication practices. Our data generation was complemented with
document analysis of materials collected online or made available via our
1 This institutional and epistemic setting is important because historically biomedical research evaluation
has been particularly responsive towards quantification and standardization, with the earliest Dutch
science policy document on assessing the sciences focusing on the medical sciences (RAWB 1983). The
RAWB report was promoted as a model for priority setting in research, and was the first to overthrow
internal peer review as the sole source for assessment by including citation analysis (Wouters 1999).
Since then, the use of performance indicators for medical research is increasingly favored over peer
review by policymakers in the Netherlands (IRMEC 2005; VWS 2006).
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informants, including annual review forms, institutional performance targets, and
communications such as emails. Names of all individuals and organizations have
been anonymized. The materials where necessary were transcribed into electronic
form and uploaded onto the Nvivo qualitative software package.
The themes we present below emerged by combining sensitivity towards existing
sociological literature with emerging insights from the data. As far as possible we
tried to adopt an open-ended and inductive stance. A case in point is that we had not
set out to study one indicator in particular, but the role of metrics in general. Yet by
zooming-in on uses of indicators in UMC research settings, we found no single
indicator divided opinions and practices as much as the JIF. Its central focus in this
article reflects its widespread presence in our data, which in turn can be fed-back in
with ongoing debates on researchers’ uses of the JIF in interesting and original
ways.
The Journal Impact Factor in Biomedical Research Practices
Thomson Reuters publicize the JIF annually using their Journal Citation Reports
(JCR), measuring the average number of citations per paper from a journal during
the two years preceding the publication of the JCR. It is calculated by dividing A)
the number of citations in the current year to items published in that journal in the
past two years by B) the total number of citable articles in the two previous years. In
a reflective account, the American chemist who first developed the indicator –
Eugene Garfield – recognizes that today the indicator has become ‘utilized in most
countries to evaluate institutions, scientific research, entire journals, and individual
articles’ (Garfield 2003: 363). Yet many claim that the JIF has extended even
further:
Nowadays it is used as a direct reflection of a journal’s prestige or quality.
Journal editors and publishers communicate the values of impact factors of
their journals to reading audiences. Impact factors are not only used to rank
journals, but to evaluate individual scholars and research groups or depart-
ments they select for publication, even in decisions about salaries or
promotion (Moed 2005: 91–92).
Within a later article Garfield remarked that uses have gone far beyond what he had
originally envisaged and goes on to evaluate its contemporary influence as a ‘mixed
blessing’(Garfield 2006). However, others have been less equivocal. Researchers in
the field of scientometrics (dedicated to the construction and advancement of
existing and new bibliometric indicators), with which Garfield is usually associated,
are quite often robust in their criticisms. Much of the discourse here takes a
normative stance, concerning ‘what is to be done’ with regards the ‘unintended
effects’ bibliometric products come to have in an era of rapidly expanding academic
audit (Weingart 2005; Van Dalen et al. 2012). In 2012, a leading journal in the field
– Scientometrics – produced a special issue concentrating on the JIF’s uses and
misuses (Braun 2012). Arguments against the JIF often cite a number of technical
shortcomings (Moed and van Leeuwen 1996; Buela-Casal and Zych 2012), for
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instance, in claiming it a ‘faulty method’ or as ‘widely open to manipulation by
journal editors and misuse by uncritical parties’ (Archambault and Larivie`re 2009:
635). Research managers have been identified as a group especially prone to
(mis)using indicators in recent sociological accounts of academic governance and
research cultures (Gla¨ser and Laudel 2007; Woelert 2015). Social scientists are not
alone in voicing their concerns. In 2013, the Nobel Prize-winning biologist Randy
Schekman produced a high profile criticism of practices in biomedicine, stating that
the JIF has become a performance standard now dominating research practices
(Schekman 2013). In 2012, a critical list of declarations – The San Francisco
Declaration on Research Evaluation (DORA) – was launched by biomedical
scholars and journal editors about the role the JIF plays in academic life. The
statement warns against various applications of the JIF in research assessment
contexts (actual evaluation, promotion or hiring, awarding grants), and reiterated a
number of ‘widely accepted’ criticisms – both ‘technical’ and ‘social’ –
undermining the JIF as a scientific quality indicator. In doing so DORA calls for
‘funding agencies, academic institutions, journals, organizations that supply
metrics, and individual researchers’ alike to drop the indicator (DORA 2013).
Another medium in which the JIF’s influence gets discussed perennially is
prestigious biomedical journals. A recent statement by then Editor-in-chief of
Journal of Cell Biology expressed support for DORA and cites a number of ways
the JIF feeds into the ‘culture’ of biomedicine:
The [J]IF is pervasive in the scientific community. Scientists refer to it
casually in conversation to convince colleagues of the importance of their own
papers, or they wonder how a paper ended up in ‘‘a journal with such a high
Impact Factor.’’ Students and postdocs want to publish only in ‘‘high Impact
Factor’’ journals, and the [J]IF is frequently used in recruitment, tenure, and
granting decisions when a candidate’s past publication performance is
assessed (Misteli 2013: 651).
An earlier article in the British Medical Journal echoes a concern voiced among
journal editors on the kinds of knowledge being produced, given that maintaining
‘respectable’ JIF scores necessitates editorial practices focusing ‘more and more on
citations and less and less on readers’ (Brown 2007: 561). Together these accounts
capture a set of ‘folk theories’ (Rip 2006) about roles and influence of the JIF in
biomedicine, which are well publicized and by implication feed-back into
researchers own practices concerning the JIF. But whether such general statements
and assumptions about indicators translate seamlessly into biomedical research
settings, and whether they do so in similar ways for different sub-fields is a topic for
our analysis, rather than a starting assumption. Thus whilst we have no particular
complaints with the claim that the JIF can and/or ought to be improved
methodologically, we find the above-mentioned accounts of how scientists use (or
ought to use) indicators fall short of what robust empirical analysis and
understanding can offer. In orienting towards this task we follow Dahler-Larsen’s
(2013) suggestions that oft-heard accusations of indicator ‘misuse’ would be more
productively recast for analytic purposes merely as examples of actual use; a
particular community’s ‘failure’ to follow standards of ‘proper use’ are eschewed in
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favor of accounts of the actual uses of indicators by researchers; and ‘unintended
consequences’ are transformed into ‘constitutive effects’ of indicator use (Dahler-
Larsen 2013). Indeed, a general criticism that can be made about these above
accounts is their inattention towards scientists’ own ‘folk theories’ of indicators.
Although coined by Rip in describing nanotechnologists, his definition is useful for
our purposes here:
Actors attempt to capture patterns in what is happening and be reflexive about
them, so as to do better the next time. Since there is a claim that such patterns
will recur… there is generalization, so one can speak of a theory… Calling it a
folk theory implies that it evolves in ongoing practices, and serves the
purposes of the members of the various practices. What characterizes folk
theories is that they provide orientation for future action… They are a form of
expectations, based in some experience, but not necessarily systematically
checked. Their robustness derives from their being generally accepted, and
thus part of a repertoire current in a group or in our culture more generally
(Rip 2006: 349).
The folk theories concept is helpful here as it does not take received assumptions of
the JIF as given, but rather positions its role and influence in research as a topic of
analysis. Asknes & Rip’s (2009) attention towards scientists’ folk theories of
citations would suggest notions like ‘amateur bibliometrics’ or ‘uncritical parties’
may be somewhat dismissive. Indeed, some have flagged new forms of ‘vernacular’
knowledge in the domain of evaluative bibliometrics as potentially perturbing
earlier kinds of separations made between ‘expert’ and ‘amateur’ (Cronin and
Sugimoto 2014; De Rijcke and Rushforth 2015).
The concept of judgment device will provide an additional means of describing
researchers’ engagement with the JIF. The sociologist Lucien Karpik (2010) coined
the term to describe trusted devices to which buyers in markets for ‘singularities’
delegate when making choices. Singularities are goods that face competition by
qualities rather than price (p.39), and are multi-dimensional and incommensurable.2
Andrew Abbott (2014) recently picked-up this theme to account for various tools
used by individuals and organizations to deal with situations of excess. University
rankings would be examples of judgment devices, as they facilitate prospective
students in ordering their judgments over college choices hierarchically (Abbott
2014). This ‘take the best, forget the rest’ formula is more likely to figure
in situations where choice is characterized by excess rather than by scarcity (ibid).
The appeal of bibliometric indicators is often framed in related terms, with promises
to ‘reduce complexity’ being features managers and policymakers find attractive
(Cronin and Sugimoto 2014; Woelert 2013). In evaluation contexts journal ranking
tools like the JIF help render the prestige from publishing in one journal over
another commensurable (Espeland and Stevens 1998), which is appealing in the face
of excessive choice, uncertain qualities, and/or the absence of substantive expertise.
2 The commercial imperatives of competing for market share through judgment devices (Karpik 2010:
51–52) can be extended to Thomson Reuters’ promotion of the JIF.
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How mobilizations of the JIF played-out in specific research practices is the issue to
which we will now turn.
Collaboration, Authorship, and the JIF
That scales of problems in modern biomedical knowledge making now necessitates
greater interdependencies and expanded forms of collaboration has been well
documented by historians and sociologists of science (Shrum et al. 2007). Yet
despite ‘increasing incentives to collaborate,’ preservation of the institution of
authorship retains the individual as the ‘epistemic subject’ of knowledge production
in biomedicine (cf. Knorr-Cetina 1999: 167). Recent neighboring work from
sociology of science predicts one of the major impacts of expanding formal
evaluation regimes on academic work settings is re-configuring of authority
relations among scientists, as well with their organizational context, patrons, and
stakeholders (Whitley and Gla¨ser 2007; Whitley et al. 2010). Following Whitley
(2007), tensions between the need of researchers in fields like biomedicine to
collaborate and compete may increase as various forms of quality rankings come to
‘intensify the stratification of individual researchers, research teams and employer
organisations’ (Whitley 2007: 10). As collaboration is such an important building
block of biomedical knowledge, incidences of the JIF in such contexts and its
capacity to reconfigure relations among biomedical researchers is of particular
interest. How then collaborations were organized and authorship credits distributed,
how informants mobilized the JIF as a judgment device in shaping these decisions,
and who was able to shape these relations will now be unpacked further.
Ordering Collaborations in the Laboratory
In our laboratory-based research sites producing a journal article is beyond the
competencies of an individual, with collaborations the norm. The researchers followed
a rather familiar set of authorship conventions, with the first author in principle the
individualwho produced the greatest number of figures for a paper, and second authors
having contributed fewer. The PI was by convention last author on the paper, which
signifies they initiated, facilitated, and lead on the research theme under which the
paper marks a contribution. One of the notorious effects these widely followed
arrangements give rise to is competition for first author berths. Mu¨ller’s (2012) study
of Austrian life sciences argues post-doctoral researchers are especially exposed to
first-authorship priority struggles, given their positioning at a ‘bottleneck’ between
temporary post-doc positions and dwindling numbers of permanent academic
openings. We found that PhDs also stood to benefit from high impact first author
publications in terms of making them more attractive commodities on the academic
job market. Although perhaps not mandatory to finding some post-doc position, it was
commonly felt that to acquire positions at prestigious laboratories this was essential.
We found that PIs in our research sites also faced pressures to produce last authored
publications in prestigious journals in order to account for the activities of their labs
and departments, to convert publications into grant money, and to continue attracting
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attention to the laboratory. High impact publications can be advantageous for middle-
authors, yet in this kind of authorship system the first and last authors are by common
consent always likely to reap the greatest amount of credit. It was no coincidence that
technicians were by far themost dismissive set of respondents towards the demands of
this reputational economy, as they are seldom credited as first or last authors on
publications or directly dependent on these for career progression. For those pursuing a
professorial career it is first and last authorship berths (depending on their career
phase) which promise the greatest reputational pay-off for the individual; dynamics
which we observed across our laboratory-based settings, and we suspect are rather
typical of how the JIF feeds into authorship practices for a great number of laboratory-
based biomedical research sites.
The institutionalized division of labor in these sites means it is the PI whose name
is made visible within the wider peer networks and who is responsible for duties like
attracting big grants, hiring staff, identifying promising research topics, retrieving
cutting-edge information from conferences, spotting trends in the literature, and so
on. The PI’s job is thus primarily office based, whereas junior colleagues are situated
much more at the laboratory bench, carrying out the practical embodied labor of
experiments along with technicians. In this organizational structure members of the
laboratory are ‘elements in [their leader’s] arrangement’ (Knorr-Cetina 1999: 221;
Hackett 2005). In one surgical oncology site, one challenge the PI cited was getting
part of the PhD population entering the laboratory to meet his interests in producing
high impact output. In order to do so, the PI had set a minimum requirement of
‘impact points’ each incoming student had to agree to meet before they could submit
their thesis.3 An important factor in introducing this target came from the
translational focus of the laboratory, which hosted researchers with biological and
clinical training backgrounds. Over half of the PhD students were pursuing careers as
surgical specialists in the Netherlands, rather than as academic scientists:
It used to be different, because the bar was set at four publications as a
requirement for the PhD. But then we noticed that the [surgical] PhD students
were going for minor papers; ‘‘As soon as I have these four papers, I can get
my PhD, and then I can go into training, or at least I can apply for a training
position.’’ And already, 10 years ago, when we started, we said, ‘‘Okay, we
have to do this differently, because we’re aiming for quality,’’ because if
you’re not producing quality, you’re not going to get grant money. Nobody’s
going to give you a grant if you have four papers in an impact factor one
journal, but you may get a grant based on a paper that you published in an
impact factor 12 journal or higher, right? And so at that time, we said, ‘‘We
have to change the requirement for getting the PhD,’’ and now, we set that bar
at 15 impact points. So if you get a paper in an impact factor 15 journal,
basically, you’re done. And we’ve really noticed a change in that stimulating
people for the quality, and go for that one nice paper.
(PI Interview, Surgical Oncology, Institute B)
3 In Dutch biomedicine it is a customary format for PhD theses to consist of published journal articles,
rather than in monograph form.
Accounting for Impact? 125
123
Aside from the tight coupling of words like ‘quality’ with the JIF, this shows the PI
will only permit those who are like-minded and agree to fulfill his ambitions and
requirements to enter at this level. Furthermore, it was the PI who was responsible
for making decisions about how to distribute resources among the laboratory. Here
the JIF was mobilized as a judgment device in evaluating work-in-progress,
sometimes influencing whether to continue supporting projects or arms of projects:
Respondent: I just had a discussion with [PhD] on a project that’s never going
to be high impact. But then we have the choice; either publish it in a lower
journal, or forget about it. And then, of course, we’re also practical and say,
‘‘Okay, we have to publish it.’’
Interviewer: Okay, yes. So you can decide whether to do more experiments on
the basis of whether you think it stands a chance in a higher impact journal.
Respondent: Of course, but then if we stick to [same PhD] as an example, she
also has projects that are running really well. And so then, my problem, or
something that I have to decide is are we actually going to invest in that
project that we don’t think is very high impact, or are we going to try to
publish it as it is, in a lower journal, so that she has all the time to work on the
projects that are going well, and that do have an interesting set of results?
(PI Interview, Surgical Oncology, Institute B)
The PI thus appears to order judgments hierarchically via the JIF, including how to
allocate scarce resources, how much encouragement and attention to give various
projects in his laboratory, and how much time to spend co-authoring a paper. Yet
rather than recognized as hierarchical commands, the relations of authority and
seniority were often framed in laboratory settings in terms of mentorship and
guidance. The early-career researchers’ reliance on the PI to mediate the social
world of science was exemplified by asymmetries in writing experiences:
Interviewer: Gets it kind of right for the journal?
Respondent: Yes, she [PI] has more experience in publishing and PIs in
general [have] more experience to make the message clearer. When you’re a
young scientist, you’re a bit crazy and you want to say everything and it makes
it a bit more confused. So PIs in general they are really good to say that is the
main message and [making it] easier to read.
(PhD Interview, Molecular Cell Biology, Institute B)
Authority of laboratory leaders over members is drawn from their ability to mediate
between ‘inside’ of the laboratory and ‘outside’ (enjoying greater access with peers,
funders, research managers and so on) (Knorr-Cetina 1999: 222, 224; Hackett
2005). Laboratory-based junior members recognized their PI’s positioning as
spokesperson for an ‘external context’ was not simply driven by interests in building
careers of lab members, but were also responsive towards sets of accountability
relations which senior researchers alone must attend (for instance, grant writing and
answering to research managers). Our materials suggest that in the laboratory-based
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biomedical settings PI’s mediations between the external context and members of
their laboratory often brought forward and negotiated the JIF as a common interest
in collaboration. In these settings then the authority of the laboratory leaders
appeared consolidate around the presence of the JIF and the imperative to score
highly on its scale.
Shaping Internal and External Collaborations
By way of contrast we will now turn our attention to the ‘outliers’ in our case: the
medical statisticians. The structure of the statistics departments in relation to
research was quite idiosyncratic and is worth outlining, as it has consequences for
how the JIF fed-into collaborative and authorship relations. Here we focus primarily
on Institute B, where there were two ‘tiers’ all staff in the department recognized:
researchers and teachers. The ‘researchers’ engaged in their own independent
research whereas ‘teachers’ did not. Those who produced their own research were
eligible for promotions along the ranks of assistant to full professor, whereas this
path was restricted for teachers. One such ‘teacher’ was in fact employed as
‘research support’ staff, whereas two more were assistant professors, hired a number
of years before the ‘research active’ members were appointed. Yet these self-
professed teachers openly expressed little desire to pursue a research career in the
way the ‘research active’ colleagues were doing. In practice the evaluation criteria
used for ‘researchers’ and ‘teachers’ differed, with the former evaluated much more
in terms of ‘traditional’ indicators (publication numbers, citations, prestige of
journals and so on), external funding, and numbers of PhD students. However, both
‘researchers’ and ‘teachers’ were responsible for contributing research output via
consulting. Therefore, to describe the forms of collaboration and authorship
characterizing knowledge production in this site, it is necessary to attend separately
to the production of research output from ‘independent’ and ‘consulting’ research
activities.
‘Research active’ members producing their own ‘independent’ publications are
engaged in a more individualistic work model compared with the laboratory sites
(where there was regular interaction at the laboratory bench, as well as weekly
supervisory meetings). The scales of their problems did not always necessitate
pooling of expertise or very large numbers of collaborators, in the way one readily
associates with the ‘big science’ era of biomedicine (cf. Biagioli 2002: 495). Much
of the time spent observing PhDs and post-docs in their offices found this activity
consisted mostly of them working on their own projects whilst sitting in silence,
typing away at their computer workstations. This comparatively individualistic
model translated into how authorship for papers got divided. In an associate
professor’s emerging research line of biostatistics, decisions to bring in a biologist
took the form of an ad hoc arrangement contingent on the perceived complexity of
the data set he was working on at that time (Fieldnotes April 3, April 15). The
following extract recounts a conversation with a PhD student regarding a
manuscript he was preparing to submit as lead author, with his supervisor and a
fellow PhD as co-authors. We discuss how typical such an arrangement was of how
they divided authorship credits:
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We talk about papers at lunch… PhD 1 says of course because X is his
supervisor, he will be co-author on his papers. PhD 2 [in the same department]
is co-author because they chat all the time and this shapes the work, so she
needs to be credited… Again he reiterates the point it is not typical to work
with another PhD student unless you have a significant overlap and it ‘makes
sense.’
(Fieldnote 17 April)
This explanation of why the manuscript has taken shape in such a way illustrates
how this member of the department frames a ‘typical’ collaboration: the role of
supervisor entails a legitimate claim to co-authorship, whilst involvement of another
PhD though atypical in this instance was worthy of co-authorship credit. Another
contrasting aspect of authorship practices with our laboratory-based sites was that
top-down pressures for PhDs and post-docs to produce high impact first author
publications were much less apparent.
To be clear, the statisticians did still produce high impact journal outputs.
However, the means through which they did so and how these outputs were used to
evaluate individuals differed markedly here to our laboratory sites. In their history
of oncology clinical trials in the United States, Keating and Cambrosio (2012: 133)
remark that medical statisticians have long been used by other sub-fields of
medicine as ‘hired-hands’ and consultants. Consulting on external clinical research
projects was the primary means through which high impact contributions (as co-
authors with clinicians) were achieved. The consultancy was divided ad hoc among
all members of the department, including research and teaching staff. This means
members of the Department with less resources or inclination to develop core
research lines (‘teaching staff’) were also able to make visible contributions to the
Department’s ‘research’ output via this authorship model. There is a striking
contrast between the dismissal of the JIF as a judgment device in producing
independent statistical research, compared with how the indicator gets used in their
negotiations as consultants with ‘clients,’ captured in the following fieldnote
recording a conversation with a member of ‘teaching’ staff:
Ethnographer: What happens if a paper they consult on gets rejected by
journals?
‘Teacher’: Well we normally take the reviewers’ comments into consideration,
then slide down the impact factors until we find a venue. This usually works
but occasionally things don’t get published…We often can have quite a bit of
editorial control about what corrections to make - particularly for our parts of
the paper.
(Fieldnote 12 May)
Despite active participation in the work, statisticians were seldom listed as first, last,
or even second authors on such papers. This example outlines a form of authority
struggle over which sub-field of biomedicine gets to identify appropriate journals (the
statisticians adapt towards their clients’ demands). A further credibility struggle
emanating through their commercial consultancy was in demonstrating the worth of
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their contribution to those tendering their services (UMC clinicians). This customer-
consultant relationship was not always straightforward to execute, especially as
receipt of payment often generated assumptions among clinicians that this frees them
of obligation to include the statisticians as co-authors. Prima facie this struggle
resembles Biagioli’s (2002) observations that growing involvement of private
funding sources in the ‘big science’ era brings about an increasing ‘entrepreneurial
ethos’ towards authorship (p. 495). In this situation the credit rather than
responsibility function of authorship gets accentuated, with authorship being treated
like a ‘trading chip in an economic game’ (Biagioli 2002: 497). The informants’
deployment of The Vancouver Protocol as an international standard in biomedical
authorship practices was one tactic they stated to negotiate this co-authorship
(dis)agreement with collaborators/customers. Members of which biomedical subfield
get to decide on order of authorship contributions (or even deny them altogether)
which becomes an emerging site of struggle in these ‘mutually beneficial’
collaborative work arrangements. This unorthodox model of pursuing high impact
publications came with some difficulties. Nonetheless as their ‘clients’ typically
favored ‘aiming high’ in terms of the JIF for their manuscripts, informants reported
that consultancy activity accrued large numbers of co-authorships in prestigious titles
across various clinical specialties. Despite these conflicts, the statisticians benefitted
from this co-authorship arrangement as it meant the department and division were
assessed very favorably within the UMC’s annual evaluations, especially when it
came to inter-Division comparisons. The Head of Department posited the explanation
that such tensions derive from resentment held by ‘customers’ outside their Division
who were paying them money and listing them as co-authors, thereby leading the
Division to perform outstandingly in UMC evaluations against which the ‘customers’
own divisions would then be unfavorably compared (Fieldnote 15 May). That these
particular co-authorship struggles were mediated by the presence of a commercial fee
was given weight by our analysis of medical statisticians in Institute A. Here the
statisticians were financially compensated for their consulting services by the UMC
board and no such quarrels over authorship were reported. The imperative to deliver
high impact publications thus poses different challenges to these two groups, which
are influenced by the organizational provisions in place. These moments underline the
different stakes which are at play in the targeting of high impact journals in
biomedicine and how different collaboration and authorship practices intersect with
this issue – sometimes amicably, other times less so.
A further consequence of statisticians’ practices of obtaining middle-author
contributions was that it did not translate very successfully into attracting individual
funding from national research councils in the Netherlands, which they claimed
typically are interested in evaluating first or last author contributions in high impact
titles (Associate professors 1&2 interviews, Institute B). This sense of frustration is
relayed in the following explanation of how the associate professor has fared in
competing for prestigious public funding at the national level:
Interviewer: Okay, what kind of sources do you look for funding…
Associate Prof: …So yeah the NWO - our national council for scientific
research - where you can ask for funding- they don’t have a line or a
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compartment in which biostatistics naturally fits in with its topics. Actually the
only thing you can apply for at NWO is personal grants… But that’s very
difficult because, for us, you should be applying within the medical pillars…
and in the medical sciences you then have to compete with those guys from the
lab who have really five Science papers already when they are thirty. We don’t
have this [in medical statistics].
This suggests that despite scoring well within UMC evaluations, the statisticians
struggle to acquire other forms of external credibility. Here a frequently heard
complaint is relayed that there is no venue for their contributions that equates to the
brand reputation and impact factor of journals like Science. Traditionally
statisticians have labored to attract large amounts of funding in medicine, often
owing to a perception they are presiding over a ‘method’ rather than ‘subject’ (like
‘cancer’) (Keating and Cambrosio 2012). Although this historical account of
(relative) institutional marginality does not cover all the complexities of our
statisticians’ situations, it resonates.
The authorship practices of medical statisticians in Institute B differed quite
markedly from the laboratory-based sciences, whether this meant producing
disciplinary contributions as ‘research active’ individuals (where the JIF is seldom
forefront in decisions over manuscripts), or contributing to external clinical research
projects as consultants (where the JIF is foregrounded, but they cannot acquire the
most sought-after authorship berths). How the statisticians’ authorship practices
interact with evaluation regimes therefore also appears quite distinct from laboratory-
sites. In one moment – annual UMC evaluations – the statistics department appears
highly successful by contributing towards their division being a top performer in the
UMC. Despite having carved out a niche within the UMC organization, their
collaboration and authorship practices come under alternative forms of pressure viaA)
the commercial exchange of a fee in their consultancy activities,where their clients see
them as paid consultants rather than academic partners, thereby often contesting the
statisticians’ authorship claims; B) the demands of external funding agencies (on those
striving for a conventional academic research career). In this latter ‘game’ of
individual grant writing they appear to perform relatively poorly compared with the
laboratory-based sites, as external legitimacy in this context seems very tightly
associated with the ability to produce first and last author publications in high impact
titles. This reiterates our point that although the JIF is an important concern across each
of the sites, how it intersects with authorship and collaboration aspects of knowledge
production at different levels of authority relations appears to vary considerably.
‘Research active’ statisticians usually worked in smaller teams of co-authors than
those in the laboratory-based sites and targeted journals with ‘relevant audiences’ and
prestige in their peer group. This appeared to shape the kinds of interactions observed
around the JIF, which wasmentioned in respect to their own independent research less
frequently, always with qualifications, and even with some irony. This irony was also
explained to us by the fact that most of these researchers have a background in
mathematics; they tended to be keenly aware of technical and mathematical
limitations in the calculation and application of seemingly straightforward indicators
such as the JIF and the H-index (Assistant professor interview, Institute A).
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Multiple demands for high impact outputs appeared to reinforce patterns of
authority based on interdependence and seniority in the laboratory-based sites.
Mu¨ller (2014) recently reported on increasing forms of instrumentalism between
post-doctoral researchers and students whom they mentor in life science settings.
For Mu¨ller possibilities for more pastoral models of supervision and co-authoring
are eroded in favor of instrumental norms and behaviors based on exchange (as
supervision is traded for getting one’s name on a paper). In situations where first and
last author publications are especially de rigueur and a homogenous indicator
persists, instrumental relations towards authorship and journal targeting of this kind
are arguably likely to intensify (ibid). We would add that although there were some
signs that the JIF and the stakes associated with it can be seen to intensify such
instrumental relations around publication activities between senior and junior
figures (not just at the level of post-docs and students), our findings on this point are
tentative and require follow-up research.
The JIF and Targeting of Journals: Scientists’ Folk Theories
The prestige associated with publishing in reputable journals acts as a powerful
incentive that scientists will almost always consider in the course of their work.
Prestige here can be understood as a product of knowledge work which gets
captured and mobilized as an ‘exchange good’ by academic scientists (Stephan
2012). But what reputational criteria do biomedical scientists draw on when
targeting their work towards particular titles in the course of their research? Are
such considerations becoming ever more tightly coupled with the JIF, or do other
considerations still factor? The primary empirical materials in this section are taken
from observations of supervisory meetings between senior and junior researchers in
the process of preparing together manuscripts for submissions to journals. These
occasions are useful entrance points not only to illustrate how JIF functions as a
‘judgment device’ in mundane research settings, but also to compare folk theories
about the indicator. We show these respective folk theories are consequential
insofar as they shape researchers’ A) sense-making; B) potential actions they sought
to take, and, importantly, C) the knowledge they create.
Grading for Novelty and Quality
Surgical oncologists usually expressed little ambivalence regarding the reliability
(and indeed validity) of JIF as a judgment device in their work. During meetings and
interviews a consistent folk theory was projected linking impact factor to the
demands for novelty and competitiveness from a given journal. Oncologists
reasoned the novelty demanded by journal gatekeepers rested on the identification
of a novel biological mechanism linked to cancer development in cells. In this
‘mission-oriented’ epistemic culture this identification is valued because it harbors
greater promises for clinical translation. Contributions to knowledge that fall short
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of the mechanism threshold get counted as ‘descriptive,’ with little prospect for
being taken up into subsequent translational, proof-of-principle studies. Descriptive
contributions are found only in the lower impact journals that are considered less
reputable. The following moment begins with a supervisory meeting between a
surgical oncology PI, his PhD student, and a post-doc, who are discussing a
manuscript they were preparing for publication together. The following exchange
exemplifies how oncologists mobilized this folk theory in the course of decision-
making about where to target the manuscript:
[PI] goes to computer. PI: Any alternatives? Any journals?
… PhD: Hmm maybe Journal C. They are similar in impact right?
Post-doc: Yeah seven-ish. It’s difficult because some papers are descriptive
and some have mechanism. So for this paper it could actually go one step
higher than Journal C because you’re going a bit beyond description. They
also have priority reports in Journal B.
PI: Journal D also have [sic] very fast publishing periods from date of
submission - if they like it of course.
(Fieldnote 22 July)
In this particular instance potential for the manuscript to ‘go beyond description’
prompts the post-doc to suggest they disqualify (initially) Journal C and go ‘one
step higher.’ This correlation between the JIF and a journal’s novelty requirements
has clear links to why some titles are more reputable than others. However,
‘novelty’ is not the only requirement of the top-tier impact journals in their field:
some respondents argued the amount of rigor and labor required to show beyond
doubt the strength of one’s claim to have identified a given mechanism (‘quality’),
correlate reliably with the impact score of journals in their field. The promise of
capturing higher prestige also makes high impact titles more competitive and the
journals are able in turn to reject articles that do not prove mechanisms. This sense
of tighter editorial policing was evident later in the conversation:
PI: I know I said Journal A but I don’t know if it’s good now. I reviewed a
couple of papers for them recently and it’s an unbelievable amount of work
expected of authors.
PhD: Yes it’s high impact.
(Fieldnote 22 July)
The JIF emerges here as a judgment device for betting on the likelihood of rejection.
This linking of journal reputations to impact factors in this sub-field rests on
assumptions about how papers are generally cited among their peers. The PI states:
The thing is we published data in journals with 2 or 3 impact before, they may
not be bad journals but you are lucky if it gets cited ten times over the years.
So what is the point in sending it there?
(Fieldnote 8 July)
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The reasoning here is that articles appearing in high impact journals generally
attract larger citation numbers precisely because they are published in high impact
journals. This ‘Matthew Effect’ appears to suggest the very citing of articles among
their peers is informed hierarchically via the impact factor score of the journal in
which they are published. The above extracts show oncologists’ folk theories of the
JIF have important implications for how they evaluate their own work-in-progress
(is it ‘good enough’ for the higher impact title, is the manuscript ‘wasted’ if it goes
to this lower impact title and gets accepted straight away, can we get it higher than it
‘deserves’?). This crucially shapes decisions about whether or not to continue
working on the manuscript, for instance, if another set of experiments and figures
are needed in order for it to ‘stand a chance’ at high impact title, or whether to settle
for lower impact. It suggests then that JIF-talk is more than simply informal
publication-talk through which biomedical researchers typically evaluate colleagues
and peers (contra Knorr-Cetina 1999: 222–224). As with the surgical oncologists,
molecular cell biologists in our study often used argumentative registers about
novelty and quality/rigor of contributions demanded by the top journals to explain
their theories of the indicator. The following moment intersects a meeting between a
PI and two PhD students discussing a manuscript they were working on. The PI has
posed the question to the students of what the manuscript is ‘worth’ in terms of JIF
points. One of the students provided a joking comment that they would send it to the
prestigious Nature. This form of joke was common across our material when
observing scientists discuss manuscript destinations. The response of the professor –
also typical across our material – was to laugh along but also remind the student to
‘be realistic.’ Such exchanges suggest the JIF is consistently taken as a reliable
judgment device to bet on likely rejection rates of different journals. Once the joke
has passed, the informants move to discussing novelty:
PhD 1: I think it is new…it is specific to mammalian cells… maybe Journal A.
I don’t know.
Prof: What is new is that we provide insights into an important pathway - that
is the underlying message. We identify the specific pathway mediated by this
machinery.
PhD 1: Let’s go for a seven. If we really manage to describe the marker then
that really is new.
PhD 2: Well we don’t know all the proteins yet.
Prof: We can only talk about what we show here.
(Fieldnote 30 June)
Their scoring of the manuscript revolves initially around the novelty of the figures
they have produced and have printed out on the A4 paper in front of them, with the
professor adopting a position of a skeptical reader who the PhDs have to persuade
about the value of the paper (measured in terms of impact score). Here then, as with
the surgical oncologists, the cell biologists draw on assumptions that the JIF
correlates more-or-less to the novelty of contributions in a given journal.
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Ambivalence
Thus far interactions in the two laboratory settings appear to posit the JIF as a
reliable indicator for estimating novelty and quality of a particular title and thereby
its likely levels of editorial rigor and rates of rejection. However, later in the same
discussion among molecular biologists ambivalence was expressed when part of the
common theorizing about the JIF was explicitly queried by one of the PhDs:
R: I always see [studies] in Cell [a high impact journal] and honestly they are
not that good, I cannot see it as any different from our papers…
At which point the professor responds:
Prof: It is the quality of the data that makes the difference. The message now is
always the impact factor.
(Fieldnote 30 June)
The theory about the ‘quality’ of figures that top-tier impact journals demand of
published papers was mobilized by the professor to repair the JIF as a common
matter of importance in the conversation. This demonstrates how labor is needed to
(re)incorporate the JIF into the social and material realities of doing research,
particularly if fault lines emerge in respondents’ theorizing of the JIF. Interestingly,
questions of how desirable it was to obtain a higher impact score and justifications
for why it was important were regularly raised by the informants in this molecular
biology group, in marked contrast with the surgical oncologists in our study, where
widely discussed issues regarding general shortcomings or criticisms of the
indicator were largely absent.
When compared to cancer-related sub-fields, medical statistics journals do not
generally carry high impact scores. This makes for a non-standard story of how
‘research active’ members from this site incorporated the JIF into their work. Those
members who are evaluated in terms of their research contributions as individuals
have an ambivalent relationship with the indicator. The following account from a
PhD was typical of statisticians’ responses:
I: And do you look at things like the JIF?
PhD: Impact factor. Well it’s a bit difficult especially in a statistics field where
most of the journals don’t really have high impact factors. For instance, in a
journal like Journal A, it is really a good journal in medical statistics, but it
will only have like two-point-something [JIF score]. But if you go to a general
epidemiology journal, then two-point-something is a very low journal. They
will usually aim for something like seven or ten impact factor. But for us two-
point-something is really high.
(PhD interview, statistics, Institute B)
On the one hand, the PhD is aware of the disparity between impact scores of
journals between medical sub-fields as even those neighboring their own
(epidemiology) publish in much higher scoring titles. Yet this does not lead to
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complete dismissal of the indicator when identifying journals within the scope of
their statistical specialty, but only a claim that it is misleading when comparing
between sub-fields. This epistemological argument was typical of theorizing about
the JIF across statistics sites. The attributed shortcomings were palpable in one
instance where the PhD and her associate professor supervisor had sent a co-
authored paper to a multi-disciplinary journal as a ‘last resort,’ having been rejected
from six statistical journals they had considered more prestigious. Ironically, this
‘last resort’ had almost double the impact score as the statistics journals that had
rejected the manuscript. In circumstances where they sought recognition from
publishing in statistical titles additional criteria were brought forward like the
journal’s ‘fit’ with their given topic, relevance of its readership, and likelihood of
accruing future citations. This suggests a heavily qualified folk theory about the
reliability of the JIF in relation to prestige of statistical journals: it does not convey
well the novelty or contribution of a particular article to those outside the sub-field.
The statisticians’ example demonstrates that widespread propensity to promote
impact scores throughout biomedicine does not always sync with how scientists in
certain sub-cultures of biomedicine attribute reputation in targeting journals. Yet it
is also notable that despite all these subtle gradations in the statisticians’ theorizing,
the JIF was still present in their knowledge making process. As a de facto
performance standard, the indicator was much more readily incorporated as a
judgment device into laboratory scientists’ decision-making around actions to be
taken on manuscripts. Here the JIF appears to be much more tightly correlated with
aspects of novelty and quality journals demand of submitted manuscripts. Of course,
it is highly likely that informants’ folk theories were themselves responsive towards
folk theories in wider circulation across the social world of biomedicine, which
acquire a kind of self-fulfilling effect (Rip 2006). A consequence for work in these
laboratory settings is that JIF-considerations seemed to mediate and sometimes
eclipse judgments of the kind statisticians were making about journals, like
readership particular titles typically attract, or the reputations a title carries among
peers. However, the uses of the JIF are multi-dimensional and laboratory-based
scientists do, of course, still make qualitative judgments about where to send
manuscripts (c.f. Karpik 2010). Our findings here lead us to form the tentative
suggestion that when issues like novelty and priority of findings become ever more
synonymous with the JIF, then aspects of knowledge production like journal
targeting will become increasingly attuned and attentive towards this pre-defined
indicator.
Conclusion
At present a number of folk theories percolate in the world of biomedical science
about the relative importance and role of the JIF. Whilst these public statements
characterize the indicator as part of ‘the culture’ of biomedicine at large (e.g. Brown
2007; Misteli 2013), they stop short of stating that it has been incorporated into
biomedicine’s ‘epistemic culture(s).’ Contrary to these moves, we have analyzed
here two building blocks of biomedical knowledge production the JIF latches onto
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as a judgment device: A) collaboration and authorship practices; and B) assessing
work-in-progress manuscripts and how novelty of work and reputation of journals
are evaluated. Taken together, our findings suggest this indicator should not be
dismissed as mere idle ‘publication talk,’ or as floating in some external ‘cultural’
realm separated from the ‘serious business’ of knowledge making. Likewise
statements of discontent tend to implicate the entire field of biomedicine as captured
by the JIF, yet the comparative scope of our findings raises the question of which
sub-cultures are more-or-less attentive to JIF-considerations and how might this
differ. A more general problem with many received criticisms of the indicator is
they primarily focus on epistemological properties, suggesting this is the level on
which researchers typically engage the indicator. It was possible, however, for
informants to be aware of epistemological limitations, whilst simultaneously
recognizing an article in a high impact title was ‘the ticket’ needed to secure a grant
or job position. Thus even if informants do not necessarily mobilize the JIF
primarily as an epistemological device to calculate quality, this does not mean there
was complete absence of sociological theorizing or blanket ignorance about the
indicator. For this reason we feel ambivalent about statements coming from
scientometricians that the JIF ‘misleads.’ By limiting indicator uses to questions of
validity, movements like DORA also assume displacing the JIF for ‘better’ (i.e.
more valid) indicators would necessarily give rise to better evaluation practices.
Again this ‘modest proposal’ appears to be borne out of the assumption that the JIF
is external of ‘core’ research practices. Our findings suggest that in calling for
researchers to ‘drop’ the JIF, DORA is actually calling for transformations in how
biomedical knowledge is manufactured. Although calls for better indicators are
difficult to refute in principle, our findings serve to remind that in research practice
‘better epistemological indicators’ will always generate their own constitutive
effects (Dahler-Larsen 2013).
Whilst we recognize the thrust of certain arguments concerning homogenization of
performance evaluation around the JIF in biomedicine, the ethnographicmaterialwe put
forward about scientists’ work patterns around the indicator can help qualify such
assumptions, including also those found in critical social science domains. Treating
quantitative indicators as merely receptacles for top-down control over academics risks
downplaying how indicators acquire additional meanings through their uses (Dahler-
Larsen 2013). In some of our biomedical sites indicator uses may be said to ‘conform to
types’ set-out in critical studies, yet in other moments they appear confounding. Even in
settings where a single indicator – like the JIF – appeared an obligatory concern to all,
there are still other forms of information and indicators being filtered through the JIF,
which go beyond generalized profiles of researcher ‘responses’ or ‘perceptions.’ Rather
than undermining then the claim that the JIF now dominates biomedicine, our study
textures these accounts and evokes detailed empirical materials as the basis for further
reflection and theoretical enrichment of its presence within this important field of
research. Our employment of the term ‘judgment device’ to conceptualize use of the JIF
– whilst insightful – requires qualification. Although the indicator appears to meet a
number of abstracted characteristics, Karpik’s (2010) original argument that judgment
devices enjoy widespread trust among users ought to be tempered by consideration that
respondents here were knowledgeable about some widely-discussed criticisms of the
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JIF. Here then it is instructive to distinguish between the JIF’s assumed reliability in
contexts of use (whichwas strong) and validity as ameasure of quality in science (which
respondents conceded was open to questioning). Detailed empirical examinations of
indicators in other epistemic and organizational settings would enrich theories of
indicator use in sociological studies of science andhigher education, and informongoing
normative and political debates surrounding the ‘crisis’ of quantitative indicators in
science. We hope our findings can provide a platform for further research into the
presence of the JIF in different regional and epistemic contexts, in order that the
implications of this controversial indicator might be more fully considered.
Acknowledgments Earlier versions of this work were presented in 2014 at EUSPRI Early Careers
Conference, Ingenio, Valencia and in the EGOS Annual Conference held in Erasmus University,
Rotterdam. Thanks to those who organized and attended our sessions. We are grateful to colleagues for
their helpful feedback on the paper and for ongoing support: Jochen Gla¨ser, Paul Wouters, Tjitske
Holtrop, Thomas Franssen, Joost Kosten, Clifford Tatum, Bjo¨rn Hammarfelt, Thed van Leeuwen. Thanks
to two anonymous referees and the editorial team at Minerva, and of course to those who participated in
the study.
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, dis-
tribution, and reproduction in any medium, provided you give appropriate credit to the original author(s)
and the source, provide a link to the Creative Commons license, and indicate if changes were made.
References
Abbott, Andrew. 2014. The Problem of Excess. Sociological Theory 32(1): 1–26.
Aksnes, D.W., and A. Rip. 2009. Researchers’ perceptions of citations. Research Policy 38(6): 895–905.
Archambault, E´ric, and Vincent Larivie`re. 2009. History of the journal impact factor: Contingencies and
consequences. Scientometrics 79(3): 635–649.
Biagioli, M. 2002. The instability of authorship: Credit and responsibility in contemporary biomedicine.
In Science Bought and Sold, eds. P. Mirowski, and E.-M. Sent. Chicago: University of Chicago
Press.
Bleiklie, Ivar, and Svein Michelsen. 2013. Comparing HE policies in Europe. Higher Education 65(1):
113–133.
Braun, Tibor. 2012. Editorial. Scientometrics 92(2): 207–208.
Brown, Hannah. 2007. How impact factors changed medical publishing—and science. BMJ 334(7593):
561–564.
Buela-Casal, Gualberto, and Izabela Zych. 2012. What do the scientists think about the impact factor?
Scientometrics 92(2): 281–292.
Burrows, R. 2012. Living with the h-index? Metric assemblages in the contemporary academy.
Sociological Review 60(2): 355–372.
Cozzens, Susan E., and Julia E. Melkers. 1997. Use and Usefulness of Performance Measurement in State
Science and Technology Programs. Policy Studies Journal 25(3): 425–435.
Cronin, B., and C. Sugimoto. 2014. The bibliometrics baby and the bathwater. In Scholarly Metrics
Under the Microscope: From Citation Analysis to Academic Auditing, eds. B. Cronin, and C.
Sugimoto. Medford, New Jersey: Information Today.
Dahler-Larsen, Peter. 2012. The evaluation society. Stanford, California: Stanford University Press.
Dahler-Larsen, Peter. 2013. Constitutive Effects of Performance Indicators. Public Management Review
16(7): 969–986.
De Bellis, Nicola. 2009. Bibliometrics and citation analysis: From the science citation index to
cybermetrics. Scarecrow Press.
Accounting for Impact? 137
123
De Rijcke, S., and A. Rushforth. 2015. To intervene, or not to intervene; is that the question? On the role
of scientometrics in research evaluation. Journal of the Association for Information Science and
Technology. doi:10.1002/asi.23382
DORA. 2013. San Francisco Declaration on Research Assessment. http://www.ascb.org/dora-old/files/
SFDeclarationFINAL.pdf. Accessed 11 Nov 2014.
Espeland, W.N., and M. Stevens. 1998. Commensuration as a social process. Annual Review of Sociology
24: 313.
Fealing, Kaye Husbands. 2011. The Science of Science Policy: A Handbook. Stanford, Calif.: Stanford
University Press.
Feller, Irwin. 2009. Performance measurement and the governance of American academic science.
Minerva 47(3): 323–344.
Felt, Ulrike, Alice Cˇervinkova´, and Jutta Ahlbeck-Rehn. 2009. Knowing and living in academic research:
Convergences and heterogeneity in research cultures in the European context. Institute of Sociology
of the Academy of Sciences of the Czech Republic.
Garfield, E. 2006. The history and meaning of the journal impact factor. JAMA 295(1): 90–93.
Garfield, Eugene. 2003. The meaning of the impact factor. Revista Internacional de Psicologı´a clı´nica y
de la Salud 3: 363–369.
Geuna, Aldo, and Ben R. Martin. 2003. University research evaluation and funding: An international
comparison. Minerva 41(4): 277–304.
Gla¨ser, Jochen, and Grit Laudel. 2007. The Social Construction Of Bibliometric Evaluations. In The
Changing Governance of the Sciences, eds. Richard Whitley, and Jochen Gla¨ser, 101–123.
Sociology of the Sciences Yearbook. Netherlands: Springer.
Hackett, Edward J. 2005. Essential Tensions: Identity, Control, and Risk in Research. Social Studies of
Science 35(5): 787–826.
IRMEC. 2005. Report on the research management of the university medical centers in the Netherlands.
Amsterdam: International Research Management Evaluation Committee.
Karpik, Lucien. 2010. Valuing the unique: the economics of singularities. (Transl. N. Scott & R. Shimer).
Princeton, NJ: Princeton University Press.
Keating, Peter, and Alberto Cambrosio. 2012. Cancer on trial: oncology as a new style of practice.
Chicago; London: The University of Chicago Press.
Keevers, Lynne, Lesley Treleaven, Christopher Sykes, and Michael Darcy. 2012. Made to Measure:
Taming Practices with Results-based Accountability. Organization Studies 33(1): 97–120.
Knorr-Cetina, K. 1999. Epistemic Cultures: How the Sciences Make Knowledge. Cambridge, MA:
Harvard University Press.
Kru¨cken, Georg, Albrecht Blu¨mel, and Katharina Kloke. 2013. The managerial turn in higher education?
On the interplay of organizational and occupational change in German academia. Minerva 51(4):
417–442.
Leisyte, Liudvika, and Jay R. Dee. 2012. Understanding Academic Work in a Changing Institutional
Environment. In Higher Education: Handbook of Theory and Research, 123–206. Springer.
Luukkonen, Terttu. 2014. The European Research Council and the European research funding landscape.
Science and Public Policy 41(1): 29–43.
Misteli, Tom. 2013. Eliminating the impact of the Impact Factor. The Journal of Cell Biology 201(5):
651–652.
Moed, H. F. 2005. Citation analysis in research evaluation. Information science and knowledge
management, vol. 9. Dordrecht: Springer.
Moed, H.F., and T.N. van Leeuwen. 1996. Impact factors can mislead. Nature 381(6579): 186.
Mu¨ller, Ruth. 2012. Collaborating in life science research groups: The question of authorship. Higher
Education Policy 25(3): 289–311.
Mu¨ller, Ruth. 2014. Postdoctoral Life Scientists and Supervision Work in the Contemporary University:
A Case Study of Changes in the Cultural Norms of Science. Minerva 52(3): 329–349.
Nedeva, Maria, Rebecca Boden, and Yanuar Nugroho. 2012. Rank and File: Managing Individual
Performance in University Research. Higher Education Policy 25(3): 335–360.
NFU. 2008. University Medical Centres in the Netherlands. Utrecht: NFU.
Opthof, T., and A.A. Wilde. 2011. Bibliometric data in clinical cardiology revisited. The case of 37 Dutch
professors. Netherlands Heart Journal 19(5): 246–255.
Parker, Martin, and David Jary. 1995. The McUniversity: Organization, management and academic
subjectivity. Organization 2(2): 319–338.
Power, Michael. 1997. The audit society: rituals of verification. Oxford: Oxford University Press.
138 A. Rushforth, S. de Rijcke
123
Reale, Emanuela, and Marco Seeber. 2013. Instruments as empirical evidence for the analysis of Higher
Education policies. Higher Education 65(1): 135–151.
Rip, Arie. 2006. Folk theories of nanotechnologists. Science as Culture 15(4): 349–365.
Sauder, Michael, and Wendy Nelson Espeland. 2009. The Discipline of Rankings: Tight Coupling and
Organizational Change. American Sociological Review 74(1): 63–82.
Schekman, R. 2013. How journals like Nature, Cell and Science are damaging science. The Guardian
Monday 9 December.
Schimank, Uwe. 2005. ‘New public management’ and the academic profession: Reflections on the
German situation. Minerva 43(4): 361–376.
Shore, Cris. 2010. Beyond the multiversity: Neoliberalism and the rise of the schizophrenic university.
Social Anthropology 18(1): 15–29.
Shrum, Wesley, Joel Genuth, and Ivan Chompalov. 2007. Structures of scientific collaboration.
Cambridge, MA: MIT Press.
Stephan, Paula E. 2012. How economics shapes science. Cambridge, MA: Harvard University Press.
Van Dalen, Hendrik P., and Kene Henkens. 2012. Intended and unintended consequences of a publish-or-
perish culture: A worldwide survey. Journal of the American Society for Information Science and
Technology 63(7): 1282–1293.
Van Eck, Nees Jan, Ludo Waltman, Anthony F.J. van Raan, Robert J.M. Klautz, and Wilco C. Peul. 2013.
Citation Analysis May Severely Underestimate the Impact of Clinical Research as Compared to
Basic Research. PloS one 8(4): e62395.
VWS, Ministry. 2006. Publieke functies van de UMC’s in een marktomgeving. Den Haag.
Weingart, Peter. 2005. Impact of bibliometrics upon the science system: Inadvertent consequences?
Scientometrics 62(1): 117–131.
Whitley, Richard. 2007. Changing governance of the public sciences. In The Changing Governance of the
Sciences: The Advent of Research Evaluation Systems. Sociology of the Sciences Yearbook, eds.
R. Whitley, and J. Gla¨ser, 3–30. Dordrecht: Springer.
Whitley, Richard, and Jochen Gla¨ser (eds.). 2007. The changing governance of the sciences: The advent
of research evaluation systems. Sociology of the Sciences Yearbook, vol. 26. Dordrecht, the
Netherlands: Springer.
Whitley, Richard, Jochen Gla¨ser, and Lars Engwall (eds.). 2010. Reconfiguring knowledge production:
changing authority relationships in the sciences and their consequences for intellectual innovation.
Oxford; New York: Oxford University Press.
Willmott, Hugh. 2011. Journal list fetishism and the perversion of scholarship: Reactivity and the ABS
list. Organization 18(4): 429–442.
Woelert, Peter. 2013. The ‘Economy of Memory’: Publications, Citations, and the Paradox of Effective
Research Governance. Minerva 51(3): 341–362.
Woelert, Peter. 2015. Governing Knowledge: The Formalization Dilemma in the Governance of the
Public Sciences. Minerva 53(1): 1–19.
Wouters, P. 1999. Beyond the holy grail: From citation theory to indicator theories. Scientometrics 44(3):
561–580.
Wouters, P. 2014. The Citation from Culture to Infrastructure. In Next Generation Metrics: Harnessing
Multidimensional Indicators of Scholarly Performance, eds. B. Cronin, and C. Sugimoto.
Cambridge, MA: MIT Press.
Accounting for Impact? 139
123
